AJP - Lung Add DOIs to your references at manuscript stage!
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Lung Cell Mol Physiol 294: L865-L873, 2008. First published January 11, 2008; doi:10.1152/ajplung.00079.2007
1040-0605/08 $8.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplemental Figure
Right arrow All Versions of this Article:
294/5/L865    most recent
00079.2007v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (2)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Maniatis, N. A.
Right arrow Articles by Minshall, R. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Maniatis, N. A.
Right arrow Articles by Minshall, R. D.

EDITORIAL FOCUS

Increased pulmonary vascular resistance and defective pulmonary artery filling in caveolin-1–/– mice

Nikolaos A. Maniatis,1,2,* Vasily Shinin,1,* Dean E. Schraufnagel,2,3 Shigenori Okada,2 Stephen M. Vogel,1,5 Asrar B. Malik,1,5 and Richard D. Minshall1,4,5

Departments of 1Pharmacology, 2Medicine, 3Pathology, and 4Anesthesiology and 5The Center for Lung and Vascular Biology, University of Illinois, Chicago, Illinois

Submitted 1 March 2007 ; accepted in final form 9 January 2008

Caveolin-1, the structural and signaling protein of caveolae, is an important negative regulator of endothelial nitric oxide synthase (eNOS). We observed that mice lacking caveolin-1 (Cav1–/–) had twofold increased plasma NO levels but developed pulmonary hypertension. We measured pulmonary vascular resistance (PVR) and assessed alterations in small pulmonary arteries to determine the basis of the hypertension. PVR was 46% greater in Cav1–/– mice than wild-type (WT), and increased PVR in Cav1–/– mice was attributed to precapillary sites. Treatment with NG-nitro-L-arginine methyl ester (L-NAME) to inhibit NOS activity raised PVR by 42% in WT but 82% in Cav1–/– mice, indicating greater NO-mediated pulmonary vasodilation in Cav1–/– mice compared with WT. Pulmonary vasculature of Cav1–/– mice was also less reactive to the vasoconstrictor thromboxane A2 mimetic (U-46619) compared with WT. We observed redistribution of type I collagen and expression of smooth muscle {alpha}-actin in lung parenchyma of Cav1–/– mice compared with WT suggestive of vascular remodeling. Fluorescent agarose casting also showed markedly decreased density of pulmonary arteries and artery filling defects in Cav1–/– mice. Scanning electron microscopy showed severely distorted and tortuous pulmonary precapillary vessels. Thus caveolin-1 null mice have elevated PVR that is attributed to remodeling of pulmonary precapillary vessels. The elevated basal plasma NO level in Cav1–/– mice compensates partly for the vascular structural abnormalities by promoting pulmonary vasodilation.

nitric oxide; pulmonary hypertension; fluorescent angiography; corrosion casting



Address for reprint requests and other correspondence: R. D. Minshall, Dept. of Pharmacology M/C 868, Univ. of Illinois, 835 S. Wolcott Ave., Chicago, IL 60612-7323 (e-mail: rminsh{at}uic.edu)




This article has been cited by other articles:


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
S. W. Ryter and A. M. K. Choi
Caveolin-1: a critical regulator of pulmonary vascular architecture and nitric oxide bioavailability in pulmonary hypertension
Am J Physiol Lung Cell Mol Physiol, May 1, 2008; 294(5): L862 - L864.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2008 by the American Physiological Society.